REPORT ID 3184

Global Non-Tyrosine Kinase Inhibitors Market Professional Survey Report 2017

Publish Date
12-Dec-17
Pages
112
Format
Electronic (PDF)

This report studies Non-Tyrosine Kinase Inhibitors in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Roche
    Eli Lilly
    Novartis
    Array BioPharma
    Nerviano Medical Sciences
    Pfizer
    Merck KGaA
    Astex Pharmaceuticals
    Cyclacel Pharmaceuticals
    Daiichi Sankyo
    Onconova Therapeutics
    AstraZeneca
    GlaxoSmithKline (GSK)
    Carna Biosciences
    Celgene Corporation
    Eternity Bioscience
    Jasco Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    mTOR Inhibitors
    RAF/MEK Inhibitors
    CDK Inhibitors

By Application, the market can be split into
    Liver Cancer
    Respiratory Cancer
    Brain Cancer
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Non-Tyrosine Kinase Inhibitors Market Professional Survey Report 2017
1 Industry Overview of Non-Tyrosine Kinase Inhibitors
    1.1 Definition and Specifications of Non-Tyrosine Kinase Inhibitors
        1.1.1 Definition of Non-Tyrosine Kinase Inhibitors
        1.1.2 Specifications of Non-Tyrosine Kinase Inhibitors
    1.2 Classification of Non-Tyrosine Kinase Inhibitors
        1.2.1 mTOR Inhibitors
        1.2.2 RAF/MEK Inhibitors
        1.2.3 CDK Inhibitors
    1.3 Applications of Non-Tyrosine Kinase Inhibitors
        1.3.1 Liver Cancer
        1.3.2 Respiratory Cancer
        1.3.3 Brain Cancer
        1.3.4 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Non-Tyrosine Kinase Inhibitors
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Non-Tyrosine Kinase Inhibitors
    2.3 Manufacturing Process Analysis of Non-Tyrosine Kinase Inhibitors
    2.4 Industry Chain Structure of Non-Tyrosine Kinase Inhibitors

3 Technical Data and Manufacturing Plants Analysis of Non-Tyrosine Kinase Inhibitors
    3.1 Capacity and Commercial Production Date of Global Non-Tyrosine Kinase Inhibitors Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Non-Tyrosine Kinase Inhibitors Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Non-Tyrosine Kinase Inhibitors Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Non-Tyrosine Kinase Inhibitors Major Manufacturers in 2016

4 Global Non-Tyrosine Kinase Inhibitors Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Non-Tyrosine Kinase Inhibitors Capacity and Growth Rate Analysis
        4.2.2 2016 Non-Tyrosine Kinase Inhibitors Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Non-Tyrosine Kinase Inhibitors Sales and Growth Rate Analysis
        4.3.2 2016 Non-Tyrosine Kinase Inhibitors Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Non-Tyrosine Kinase Inhibitors Sales Price
        4.4.2 2016 Non-Tyrosine Kinase Inhibitors Sales Price Analysis (Company Segment)

5 Non-Tyrosine Kinase Inhibitors Regional Market Analysis
    5.1 North America Non-Tyrosine Kinase Inhibitors Market Analysis
        5.1.1 North America Non-Tyrosine Kinase Inhibitors Market Overview
        5.1.2 North America 2012-2017E Non-Tyrosine Kinase Inhibitors Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Non-Tyrosine Kinase Inhibitors Sales Price Analysis
        5.1.4 North America 2016 Non-Tyrosine Kinase Inhibitors Market Share Analysis
    5.2 China Non-Tyrosine Kinase Inhibitors Market Analysis
        5.2.1 China Non-Tyrosine Kinase Inhibitors Market Overview
        5.2.2 China 2012-2017E Non-Tyrosine Kinase Inhibitors Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Non-Tyrosine Kinase Inhibitors Sales Price Analysis
        5.2.4 China 2016 Non-Tyrosine Kinase Inhibitors Market Share Analysis
    5.3 Europe Non-Tyrosine Kinase Inhibitors Market Analysis
        5.3.1 Europe Non-Tyrosine Kinase Inhibitors Market Overview
        5.3.2 Europe 2012-2017E Non-Tyrosine Kinase Inhibitors Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Non-Tyrosine Kinase Inhibitors Sales Price Analysis
        5.3.4 Europe 2016 Non-Tyrosine Kinase Inhibitors Market Share Analysis
    5.4 Southeast Asia Non-Tyrosine Kinase Inhibitors Market Analysis
        5.4.1 Southeast Asia Non-Tyrosine Kinase Inhibitors Market Overview
        5.4.2 Southeast Asia 2012-2017E Non-Tyrosine Kinase Inhibitors Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Non-Tyrosine Kinase Inhibitors Sales Price Analysis
        5.4.4 Southeast Asia 2016 Non-Tyrosine Kinase Inhibitors Market Share Analysis
    5.5 Japan Non-Tyrosine Kinase Inhibitors Market Analysis
        5.5.1 Japan Non-Tyrosine Kinase Inhibitors Market Overview
        5.5.2 Japan 2012-2017E Non-Tyrosine Kinase Inhibitors Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Non-Tyrosine Kinase Inhibitors Sales Price Analysis
        5.5.4 Japan 2016 Non-Tyrosine Kinase Inhibitors Market Share Analysis
    5.6 India Non-Tyrosine Kinase Inhibitors Market Analysis
        5.6.1 India Non-Tyrosine Kinase Inhibitors Market Overview
        5.6.2 India 2012-2017E Non-Tyrosine Kinase Inhibitors Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Non-Tyrosine Kinase Inhibitors Sales Price Analysis
        5.6.4 India 2016 Non-Tyrosine Kinase Inhibitors Market Share Analysis

6 Global 2012-2017E Non-Tyrosine Kinase Inhibitors Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Non-Tyrosine Kinase Inhibitors Sales by Type
    6.2 Different Types of Non-Tyrosine Kinase Inhibitors Product Interview Price Analysis
    6.3 Different Types of Non-Tyrosine Kinase Inhibitors Product Driving Factors Analysis
        6.3.1 mTOR Inhibitors of Non-Tyrosine Kinase Inhibitors Growth Driving Factor Analysis
        6.3.2 RAF/MEK Inhibitors of Non-Tyrosine Kinase Inhibitors Growth Driving Factor Analysis
        6.3.3 CDK Inhibitors of Non-Tyrosine Kinase Inhibitors Growth Driving Factor Analysis

7 Global 2012-2017E Non-Tyrosine Kinase Inhibitors Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Non-Tyrosine Kinase Inhibitors Consumption by Application
    7.2 Different Application of Non-Tyrosine Kinase Inhibitors Product Interview Price Analysis
    7.3 Different Application of Non-Tyrosine Kinase Inhibitors Product Driving Factors Analysis
        7.3.1 Liver Cancer of Non-Tyrosine Kinase Inhibitors Growth Driving Factor Analysis
        7.3.2 Respiratory Cancer of Non-Tyrosine Kinase Inhibitors Growth Driving Factor Analysis
        7.3.3 Brain Cancer of Non-Tyrosine Kinase Inhibitors Growth Driving Factor Analysis
        7.3.4 Others of Non-Tyrosine Kinase Inhibitors Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Non-Tyrosine Kinase Inhibitors
    8.1 Roche
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Roche 2016 Non-Tyrosine Kinase Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Roche 2016 Non-Tyrosine Kinase Inhibitors Business Region Distribution Analysis
    8.2 Eli Lilly
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Eli Lilly 2016 Non-Tyrosine Kinase Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Eli Lilly 2016 Non-Tyrosine Kinase Inhibitors Business Region Distribution Analysis
    8.3 Novartis
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Novartis 2016 Non-Tyrosine Kinase Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Novartis 2016 Non-Tyrosine Kinase Inhibitors Business Region Distribution Analysis
    8.4 Array BioPharma
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Array BioPharma 2016 Non-Tyrosine Kinase Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Array BioPharma 2016 Non-Tyrosine Kinase Inhibitors Business Region Distribution Analysis
    8.5 Nerviano Medical Sciences
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Nerviano Medical Sciences 2016 Non-Tyrosine Kinase Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Nerviano Medical Sciences 2016 Non-Tyrosine Kinase Inhibitors Business Region Distribution Analysis
    8.6 Pfizer
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Pfizer 2016 Non-Tyrosine Kinase Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Pfizer 2016 Non-Tyrosine Kinase Inhibitors Business Region Distribution Analysis
    8.7 Merck KGaA
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Merck KGaA 2016 Non-Tyrosine Kinase Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Merck KGaA 2016 Non-Tyrosine Kinase Inhibitors Business Region Distribution Analysis
    8.8 Astex Pharmaceuticals
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Astex Pharmaceuticals 2016 Non-Tyrosine Kinase Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Astex Pharmaceuticals 2016 Non-Tyrosine Kinase Inhibitors Business Region Distribution Analysis
    8.9 Cyclacel Pharmaceuticals
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Cyclacel Pharmaceuticals 2016 Non-Tyrosine Kinase Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Cyclacel Pharmaceuticals 2016 Non-Tyrosine Kinase Inhibitors Business Region Distribution Analysis
    8.10 Daiichi Sankyo
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Daiichi Sankyo 2016 Non-Tyrosine Kinase Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Daiichi Sankyo 2016 Non-Tyrosine Kinase Inhibitors Business Region Distribution Analysis
    8.11 Onconova Therapeutics
    8.12 AstraZeneca
    8.13 GlaxoSmithKline (GSK)
    8.14 Carna Biosciences
    8.15 Celgene Corporation
    8.16 Eternity Bioscience
    8.17 Jasco Pharmaceuticals

9 Development Trend of Analysis of Non-Tyrosine Kinase Inhibitors Market
    9.1 Global Non-Tyrosine Kinase Inhibitors Market Trend Analysis
        9.1.1 Global 2017-2022 Non-Tyrosine Kinase Inhibitors Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Non-Tyrosine Kinase Inhibitors Sales Price Forecast
    9.2 Non-Tyrosine Kinase Inhibitors Regional Market Trend
        9.2.1 North America 2017-2022 Non-Tyrosine Kinase Inhibitors Consumption Forecast
        9.2.2 China 2017-2022 Non-Tyrosine Kinase Inhibitors Consumption Forecast
        9.2.3 Europe 2017-2022 Non-Tyrosine Kinase Inhibitors Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Non-Tyrosine Kinase Inhibitors Consumption Forecast
        9.2.5 Japan 2017-2022 Non-Tyrosine Kinase Inhibitors Consumption Forecast
        9.2.6 India 2017-2022 Non-Tyrosine Kinase Inhibitors Consumption Forecast
    9.3 Non-Tyrosine Kinase Inhibitors Market Trend (Product Type)
    9.4 Non-Tyrosine Kinase Inhibitors Market Trend (Application)

10 Non-Tyrosine Kinase Inhibitors Marketing Type Analysis
    10.1 Non-Tyrosine Kinase Inhibitors Regional Marketing Type Analysis
    10.2 Non-Tyrosine Kinase Inhibitors International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Non-Tyrosine Kinase Inhibitors by Region
    10.4 Non-Tyrosine Kinase Inhibitors Supply Chain Analysis

11 Consumers Analysis of Non-Tyrosine Kinase Inhibitors
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Non-Tyrosine Kinase Inhibitors Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source